Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity? [electronic resource]
- Neuropharmacology Jan 2008
- 235-43 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0028-3908
10.1016/j.neuropharm.2007.06.021 doi
Analysis of Variance Animals Cannabinoids--therapeutic use Cell Line, Tumor Cell Movement--drug effects Ceramides--biosynthesis Down-Regulation--drug effects Dronabinol--therapeutic use Glioma--drug therapy Humans Mice Models, Animal RNA Interference--physiology Rats Tissue Inhibitor of Metalloproteinase-1--metabolism Xenograft Model Antitumor Assays